Implant technology

Kevin Warwick at the University of Reading works on implant technologies which could enhance or modify functions of the limbs and the brain, or bring back functionalities lost, for example, in an accident or as a consequence of a stroke. Implants are also used for identification in "intelligent buildings" where they serve to control "personnel flows". However, the real potential of electronic implants seems to lie in the field of electronic drugs. The basics of the brain computer interface are already explored, and there are now efforts to electronically modify the function of the mind. Large software and IT companies are sponsoring this research which could result in the commercialisation of electronic drugs, functioning as anti-depressants, pain killers and the like. Evidently, the same technologies can also be used as narcotic drugs or to modify people's behaviour. The functioning of body and mind can be adapted to pre-defined principles and ideals, their autonomous existence reduced and subjected to direct outside control.

TEXTBLOCK 1/2 // URL: http://world-information.org/wio/infostructure/100437611777/100438658731
 
body and mind as defects

In an increasingly technisised world where technology has also become a determinant of value-free values, mind and body are increasingly considered as "imperfect" compared to the brilliant designs of technology. While for centuries the "weakness" of the human flesh has been the object of lamentations, the 21st century seems set to transform the genre of tragedy into a sober technological project of improvement. Within this project, men and women receive the status of "risk factor" which potentially destabilises technological systems, a circumstance which calls for correction and control measures.

Two main ways of checking the risk of "human error", as well as inefficiency, irrationality, selfishness, emotional turbulence, and other weaknesses of human beings: by minimizing human participation in technological processes, and, to an increasing extent, by technically eliminating such risk factors in human beings themselves.

Human beings, once considering themselves as the "crown of creation" or the "masters of the world" are reducing themselves to the "human factor" in globally networked technical systems, that factor which still escapes reliable calculation and which, when interacting with fast and potent technical environments, is a source of imperfection. For the human mind and body to perfect itself - to adapt itself to the horizon of perfection of science and technology - takes long time periods of discipline, learning, even biological evolution.

In the calculating thinking required in highly technisised context, mind and body inevitably appear as deficient compared to a technology which, unlike the human organism, has the potential of fast and controlled "improvement". Surely, the human organism has always been prey to defects, to "illnesses" and "disablement". Disease has therefore been one of the main motivations behind the development of Bio-ITs: Bio-ITs are being developed to help the blind get their eyesight back, the deaf to hear, the lame to walk, the depressed to be happy. Such medical applications of Bio-ITs are nothing essentially new: Captain Silver's crunch, the wheelchair, a tooth filling save the same basic purpose of correcting a physical deficiency.

But there is a much wider scope to this new development, in which the "normal" biological condition of a human being, such as proneness to death, forgetfulness, aging, inefficiency, solitude, or boredom are understood as defects which can and should be corrected. The use of ITs to overcome such "biological" constraints is often seen as the "ultimate" technological advance, even if the history of utopian visions connected to technological innovation is as old as it is rife with surprise, disappointment, and disaster.

TEXTBLOCK 2/2 // URL: http://world-information.org/wio/infostructure/100437611777/100438658726
 
Vandana Shiva

Vandana Shiva is the Director of the Research Foundation for Science, Technology and Ecology in New Delhi. She has been a tireless and one of the most original campaigners for ecological diversity, eco-feminism and against "official" development policies and commercial exploitation. Book publications include Ecofeminism (1993), Monocultures of the Mind (1993) and Biopiracy : The Plunder of Nature and Knowledge (1997

INDEXCARD, 1/3
 
Punch card, 1801

Invented by Joseph Marie Jacquard, an engineer and architect in Lyon, France, the punch cards laid the ground for automatic information processing. For the first time information was stored in binary format on perforated cardboard cards. In 1890 Hermann Hollerith used Joseph-Marie Jacquard's punch card technology for processing statistical data retrieved from the US census in 1890, thus speeding up data analysis from eight to three years. His application of Jacquard's invention was also used for programming computers and data processing until electronic data processing was introduced in the 1960's. - As with writing and calculating, administrative purposes account for the beginning of modern automatic data processing.

Paper tapes are a medium similar to Jacquard's punch cards. In 1857 Sir Charles Wheatstone applied them as a medium for the preparation, storage, and transmission of data for the first time. By their means, telegraph messages could be prepared off-line, sent ten times quicker (up to 400 words per minute), and stored. Later similar paper tapes were used for programming computers.

INDEXCARD, 2/3
 
Human Genome Project

The Human Genome Project is an international colaborative research project that aims to map the human genome. It's goal is to idenitfy the 100,000 genes of the human DNA as well as to sequence the 3 billion chemical base pairs that make up the DNA. The HGP is designed on an open source basis, i.e. the information that is obtained and stored in databases should, in principle, be available to researchers and businesses all over the world. However, the HGP's work has been challenged by private businesses such as Celera whose objective is the private exploitation of genome information.

INDEXCARD, 3/3